A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory

被引:314
作者
Hood, Leroy [1 ]
Flores, Mauricio [2 ]
机构
[1] Inst Syst Biol, Seattle, WA 98121 USA
[2] P4 Med Inst, Seattle, WA 98121 USA
关键词
CANCER MEDICINE; BIOLOGY; CELL;
D O I
10.1016/j.nbt.2012.03.004
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Systems biology and the digital revolution are together transforming healthcare to a proactive P4 medicine that is predictive, preventive, personalized and participatory. Systems biology - holistic, global and integrative in approach - has given rise to systems medicine, a systems approach to health and disease. Systems medicine promises to (1) provide deep insights into disease mechanisms, (2) make blood a diagnostic window for viewing health and disease for the individual, (3) stratify complex diseases into their distinct subtypes for a impedance match against proper drugs, (4) provide new approaches to drug target discovery and (5) generate metrics for assessing wellness. P4 medicine, the clinical face of systems medicine, has two major objectives: to quantify wellness and to demystify disease. Patients and consumers will be a major driver in the realization of P4 medicine through their participation in medically oriented social networks directed at improving their own healthcare. P4 medicine has striking implications for society - including the ability to turn around the ever-escalating costs of healthcare. The challenge in bringing P4 medicine to patients and consumers is twofold: first, inventing the strategies and technologies that will enable P4 medicine and second, dealing with the impact of P4 medicine on society - including key ethical, social, legal, regulatory, and economic issues. Managing the societal problems will pose the most significant challenges. Strategic partnerships of a variety of types will be necessary to bring P4 medicine to patients.
引用
收藏
页码:613 / 624
页数:12
相关论文
共 16 条
  • [1] Systems medicine: the future of medical genomics and healthcare
    Auffray, Charles
    Chen, Zhu
    Hood, Leroy
    [J]. GENOME MEDICINE, 2009, 1
  • [2] A predictive model for transcriptional control of physiology in a free living cell
    Bonneau, Richard
    Facciotti, Marc T.
    Reiss, David J.
    Schmid, Amy K.
    Pan, Min
    Kaur, Amardeep
    Thorsson, Vesteinn
    Shannon, Paul
    Johnson, Michael H.
    Bare, J. Christopher
    Longabaugh, William
    Vuthoori, Madhavi
    Whitehead, Kenia
    Madar, Aviv
    Suzuki, Lena
    Mori, Tetsuya
    Chang, Dong-Eun
    DiRuggiero, Jocelyne
    Johnson, Carl H.
    Hood, Leroy
    Baliga, Nitin S.
    [J]. CELL, 2007, 131 (07) : 1354 - 1365
  • [3] Nanomedicine Targets CANCER
    Heath, James R.
    Davis, Mark E.
    Hood, Leroy
    [J]. SCIENTIFIC AMERICAN, 2009, 300 (02) : 44 - 51
  • [4] Systems biology and new technologies enable predictive and preventative medicine
    Hood, L
    Heath, JR
    Phelps, ME
    Lin, BY
    [J]. SCIENCE, 2004, 306 (5696) : 640 - 643
  • [5] Hood L., 2011, GENET ENG BIOTECHNOL, V31
  • [6] Hood L, 2011, NAE J BRIDGE, V41, P46
  • [7] A Personal Journey of Discovery: Developing Technology and Changing Biology
    Hood, Lee
    [J]. ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, 2008, 1 : 1 - 43
  • [8] Predictive, personalized, preventive, participatory (P4) cancer medicine
    Hood, Leroy
    Friend, Stephen H.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (03) : 184 - 187
  • [9] Hood Leroy, 2008, Briefings in Functional Genomics & Proteomics, V7, P239, DOI 10.1093/bfgp/eln027
  • [10] A systems approach to prion disease
    Hwang, Daehee
    Lee, Inyoul Y.
    Yoo, Hyuntae
    Gehlenborg, Nils
    Cho, Ji-Hoon
    Petritis, Brianne
    Baxter, David
    Pitstick, Rose
    Young, Rebecca
    Spicer, Doug
    Price, Nathan D.
    Hohmann, John G.
    DeArmond, Stephen J.
    Carlson, George A.
    Hood, Leroy E.
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2009, 5